Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.23.2
Stockholders’ Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jan. 27, 2023
Jan. 26, 2023
Jan. 23, 2023
Jan. 31, 2020
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]                    
Preferred stock, shares authorized         10,000,000     10,000,000   10,000,000
Preferred stock, par value         $ 0.001     $ 0.001   $ 0.001
Preferred stock, shares issued         316 316   316   465
Preferred stock, shares outstanding         316 316   316   465
Options exercise price               $ 0.35    
Number of shares granted               433,665   487,473
Allocation share based compensation expense         $ 138,489   $ 167,439 $ 363,339 $ 338,415  
Unrecognized stock-based compensation expense, stock option         387,351     $ 387,351    
Weighted average remaining recognition period               1 year 5 months 1 day    
Directors [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Vesting percentage               50.00%    
Directors [Member] | December 31, 2022 [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Vesting percentage               50.00%    
19 Employees [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Vesting percentage   50.00%                
Number of shares granted   381,285                
Option strike price   $ 0.58                
2020 Stock Appreciation Rights Plan [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Options exercise price               $ 0.35    
Unrecognized share based compensation cost         $ 474,228     $ 474,228    
Weighted average remaining recognition period               1 year 9 months    
Employee Retention Agreements [Member] | 2020 Stock Appreciation Rights Plan [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Options exercise price   $ 0.58                
Common Stock [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Number of stock issued converted during period, shares               230,015    
Series D Convertible Preferred Stock [Member] | Common Stock [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Conversion of stock, shares converted           132        
Number of shares as in-kind payment, shares           43,241        
Series E Convertible Preferred Stock [Member] | Other Securities Purchase Agreement [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Conversion of stock, shares converted               48,544    
Share issued and sold during period, shares               333    
Dividend rate               9.00%    
Series E Convertible Preferred Stock [Member] | Common Stock [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Conversion of stock, shares converted           17        
Number of shares as in-kind payment, shares           655        
Series D Preferred Stock [Member] | Institutional Securities Purchase Agreement [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Common stock issued during period 270,828                  
Preferred stock, par value       $ 1,000            
Preferred stock, shares outstanding 132       0     0    
Share issued and sold during period, shares       1,640            
Dividend rate       9.00%            
Conversion price per share       $ 0.58            
Series E Preferred Stock [Member] | Institutional Securities Purchase Agreement [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Common stock issued during period     3,083              
Preferred stock, par value         $ 1,000     $ 1,000    
Preferred stock, shares outstanding     17   316     316    
Number of stock issued converted during period, shares               60,332    
Private Placement [Member] | Purchase Agreement [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Warrants to purchase shares of common stock   52,380                
Private Placement [Member] | Series D Convertible Preferred Stock [Member] | Common Stock [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Common stock issued during period           227,587        
Private Placement [Member] | Series E Convertible Preferred Stock [Member] | Common Stock [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Common stock issued during period           2,428